NCT01420653View on ClinicalTrials.gov

Maxigesic 325 Acute Dental Pain Study

PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Dental Pain
Interventions
DRUG

Maxigesic 325

Maxigesic USA (acetaminophen 325 mg + ibuprofen 97.5mg), three tablets four times a day with food for 48 hours

DRUG

Acetaminophen

Acetaminophen 325 mg, 3 tablets four times a day, with food for 48 hours

DRUG

Ibuprofen

Ibuprofen 97.5mg, three tablets four times a day, with food for 48 hours.

DRUG

Placebo

placebo, three tablets four times a day, with food for 48 hours

Trial Locations (4)

78705

Premier Research, Austin

Unknown

Clinical Trial New Zealand, Hamilton

Southern Clinical Trials, Christchurch

0622

Clinical Solutions Ltd., Auckland

Sponsors
All Listed Sponsors
lead

AFT Pharmaceuticals, Ltd.

INDUSTRY